Our results indicated that AGAP2-AS1 regulated tumor growth, apoptosis, and chemo-resistance via upregulation of MyD88 expression through binding with CBP and modifying H3K27 acetylation (Fig. 9). Here, AGAP2 is linked to neoplasm.